The FDA approved zilurgisertib tablets for the reduction of heterotopic ossification among patients aged 12 years or older ...

The FDA approved obinutuzumab for the treatment of idiopathic nephrotic syndrome in pediatric patients aged 2 years and older ...

Ioannis Pallikaris, MD, PhD, a pioneering leader in the development of LASIK, delivered this year’s ESCRS Heritage Lecture ...

A healthy 14-year-old girl is seen after several days of gradually worsening pain and swelling on the left side of her face.

Autism prevalence has not significantly changed since 2005, according to a large population-based study of schoolchildren in ...

Results showed patients who underwent rapid exchange arthroplasty for chronic periprosthetic joint infection experienced ...

Attendees at a wedding in Pennsylvania last year were sickened with a bacterial illness that investigators linked to ...

An exhibition that debuted at the 2026 European Epilepsy Congress showcased the works of artists with epilepsy to help ...

Remigromig was noninferior to ranibizumab at 52 weeks in patients with diabetic macular edema, according to a press release ...

It can cost more than $10,000 to translate an informed consent form for a clinical trial into another language, according to ...

Established evidence has long supported the use of red light therapy for radiation oncology, but emerging data suggest ...

Senators asked Heidi Overton, MD, about some critical issues in medicine during her hearing to become FDA commissioner.If ...